United States Cannabis Testing Market Forecast 2024-2032

The United States cannabis testing market is projected to develop at a CAGR of 14.7% during the forecast period 2024-2032. Diverse aspects foster market growth, such as recognition of cannabis for medical and therapeutic use by the medical fraternity, rise in the number of testing facilities, increasing legalization of the use of cannabis for medicine and research, and rising awareness about cannabis benefits aided by strong community support.

MARKET INSIGHTS

The United States cannabis testing market is experiencing an expansion in the number of testing facilities, reflecting the growing demand for comprehensive quality assurance and regulatory compliance in the cannabis industry. This increase in testing facilities signifies a proactive approach by stakeholders to ensure product safety, potency, and consistency, effectively addressing consumer concerns and regulatory requirements.

Another prominent pattern shaping the market is the increase in venture funding specifically allocated for cannabis testing initiatives. This upswing in investment highlights the industry's potential and the recognition of the importance of reliable testing processes in ensuring consumer confidence and market sustainability. Venture funding fuels innovation, technological advancements, and scalability in cannabis testing services, driving industry standards and competitiveness.

However, the market also faces restraints related to the exorbitant costs associated with laboratory analytical instruments used for cannabis testing. These instruments, such as high-performance liquid chromatography (HPLC), gas chromatography-mass spectrometry (GC-MS), and molecular testing equipment, require substantial investments in acquisition, maintenance, and skilled personnel. The cost factor poses challenges for smaller testing facilities and startups, limiting their access to state-of-the-art technology and hindering market entry and competitiveness.

Despite these challenges, the United States cannabis testing market continues to evolve, promoted by the increasing emphasis on quality assurance, regulatory compliance, and consumer safety. Innovation, strategic partnerships, and regulatory developments will play pivotal roles in addressing restraints and accessing growth opportunities in the cannabis testing domain.

COMPETITIVE INSIGHTS

Some of the major companies in the United States cannabis testing market incorporate Anresco Laboratories, DigiPath Inc, PerkinElmer Inc, etc.

Our report offerings include:

Explore key findings of the overall market
Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
Market Segmentation caters to a thorough assessment of key segments with their market estimations
Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
Key analytics: Porter's Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
The competitive landscape is the theoretical explanation of the key companies based on factors such as market share.
Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments

Product Code: 82576

1. RESEARCH SCOPE & METHODOLOGY

1.1. STUDY OBJECTIVES
1.2. METHODOLOGY
1.3. ASSUMPTIONS & LIMITATIONS

2. EXECUTIVE SUMMARY

2.1. MARKET SIZE & ESTIMATES
2.2. COUNTRY SNAPSHOT
2.3. COUNTRY ANALYSIS
2.4. SCOPE OF STUDY
2.5. MAJOR MARKET FINDINGS
- 2.5.1. INCREASE IN VENTURE FUNDING FOR CANNABIS TESTING
- 2.5.2. LABORATORIES ARE THE LARGEST CONTRIBUTOR TO CANNABIS TESTING MARKET
- 2.5.3. INHALATION CANNABIS IS THE PROMINENT CANNABIS TYPE

3. MARKET DYNAMICS

3.1. KEY GROWTH ENABLERS
- 3.1.1. RECOGNITION OF CANNABIS FOR MEDICAL AND THERAPEUTIC USE BY THE MEDICAL FRATERNITY
- 3.1.2. RISE IN THE NUMBER OF TESTING FACILITIES
- 3.1.3. INCREASING LEGALIZATION OF THE USE OF CANNABIS FOR MEDICINE AND RESEARCH
- 3.1.4. RISING AWARENESS ABOUT CANNABIS BENEFITS AIDED BY STRONG COMMUNITY SUPPORT
3.2. KEY CHALLENGES
- 3.2.1. LACK OF STANDARDIZED REGULATIONS ACROSS THE GLOBE
- 3.2.2. EXORBITANT COSTS RELATED TO THE LABORATORY ANALYTICAL INSTRUMENTS USED FOR CANNABIS TESTING

4. KEY ANALYTICS

4.1. KEY MARKET TRENDS
- 4.1.1. TESTING FOR MINOR CANNABINOIDS TAKING CENTER STAGE
- 4.1.2. INTEGRATION OF BLOCKCHAIN AND TRACK-AND-TRACE SYSTEMS INTO CANNABIS TESTING PROCESS
- 4.1.3. EMPLOYMENT OF INTEGRATED LABORATORY INFORMATION MANAGEMENT SYSTEMS (LIMS) FOR ACCURATE TEST RESULTS
4.2. PEST ANALYSIS
4.3. PORTER'S FIVE FORCES ANALYSIS
- 4.3.1. BUYERS POWER
- 4.3.2. SUPPLIERS POWER
- 4.3.3. SUBSTITUTION
- 4.3.4. NEW ENTRANTS
- 4.3.5. INDUSTRY RIVALRY
4.4. GROWTH PROSPECT MAPPING
- 4.4.1. GROWTH PROSPECT MAPPING FOR UNITED STATES
4.5. MARKET MATURITY ANALYSIS
4.6. KEY BUYING CRITERIA
- 4.6.1. COST
- 4.6.2. PRODUCT FEATURE
- 4.6.3. EFFECTIVENESS

5. MARKET BY CANNABIS TYPE

5.1. SOLID EDIBLE CANNABIS
5.2. INHALING CANNABIS
5.3. LIQUID EDIBLE CANNABIS
5.4. TOPICAL CANNABIS
5.5. OTHER CANNABIS TYPES

6. MARKET BY TEST TYPE

6.1. TERPENE PROFILING
6.2. HEAVY METAL TESTING
6.3. MICROBIAL ANALYSIS
6.4. GENETIC PROFILING
6.5. RESIDUAL SOLVENT SCREENING
6.6. POTENCY TESTING
6.7. OTHER TEST TYPES

7. MARKET BY INSTRUMENT & SOFTWARE

7.1. CANNABIS TESTING INSTRUMENT
- 7.1.1. CHROMATOGRAPHY INSTRUMENT
  - 7.1.1.1. LIQUID CHROMATOGRAPHY INSTRUMENT
  - 7.1.1.2. GAS CHROMATOGRAPHY INSTRUMENT
  - 7.1.1.3. OTHER CHROMATOGRAPHY INSTRUMENTS
- 7.1.2. SPECTROSCOPY INSTRUMENT
  - 7.1.2.1. MASS SPECTROMETRY INSTRUMENT
  - 7.1.2.2. ATOMIC SPECTROSCOPY INSTRUMENT
- 7.1.3. OTHER CANNABIS TESTING INSTRUMENTS
7.2. CONSUMABLE
- 7.2.1. SAMPLE PREPARATION PRODUCT
- 7.2.2. STANDARDS AND CRMS
- 7.2.3. CHROMATOGRAPHY COLUMN
- 7.2.4. SUPPLIES AND ACCESSORIES
7.3. CANNABIS TESTING SOFTWARE

8. MARKET BY SERVICE

8.1. CANNABIS CULTIVATOR/GROWER
8.2. CANNABIS DRUG MANUFACTURER AND DISPENSARY

9. MARKET BY END-USER

9.1. CANNABIS TESTING LABORATORY
9.2. RESEARCH INSTITUTIONS
9.3. OTHER END-USERS

10. COMPETITIVE LANDSCAPE

10.1. KEY STRATEGIC DEVELOPMENTS
- 10.1.1. MERGERS & ACQUISITIONS
- 10.1.2. PRODUCT LAUNCHES & DEVELOPMENTS
- 10.1.3. PARTNERSHIPS & AGREEMENTS
- 10.1.4. BUSINESS EXPANSIONS & DIVESTITURES
10.2. COMPANY PROFILE
- 10.2.1. ACCELERATED TECHNOLOGY LABORATORIES INC
  - 10.2.1.1. COMPANY OVERVIEW
  - 10.2.1.2. PRODUCT/SERVICE LIST
  - 10.2.1.3. STRENGTHS & CHALLENGES
- 10.2.2. AGILENT TECHNOLOGIES INC
  - 10.2.2.1. COMPANY OVERVIEW
  - 10.2.2.2. PRODUCT/SERVICE LIST
  - 10.2.2.3. STRENGTHS & CHALLENGES
- 10.2.3. PERKINELMER INC
  - 10.2.3.1. COMPANY OVERVIEW
  - 10.2.3.2. PRODUCT/SERVICE LIST
  - 10.2.3.3. STRENGTHS & CHALLENGES
- 10.2.4. ANRESCO LABORATORIES
  - 10.2.4.1. COMPANY OVERVIEW
  - 10.2.4.2. PRODUCT/SERVICE LIST
  - 10.2.4.3. STRENGTHS & CHALLENGES
- 10.2.5. DIGIPATH INC
  - 10.2.5.1. COMPANY OVERVIEW
  - 10.2.5.2. PRODUCT/SERVICE LIST
  - 10.2.5.3. STRENGTHS & CHALLENGES